Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 P.m. ET
DENVER, April 29, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe CA: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, Ma
PR NewswireApr 29 16:30 ET
Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%
Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal T
BenzingaApr 15 19:53 ET
MEDICINE MAN TECHNOLOGIES INC(SHWZ.US) Officer Buys US$105 in Common Stock
$MEDICINE MAN TECHNOLOGIES INC(SHWZ.US)$ Officer Pabon Daniel purchased 150 shares of common stock on Apr 11, 2024 at an average price of $0.7 for a total value of $105.Source: Announcement What is st
moomoo NewsApr 15 19:18 ET
Cannabis Market's Trading Volume Surges Up 292%, Viridian Capital Highlights Mixed Liquidity
A recent analysis by Viridian Capital Advisors provides intriguing insights into the liquidity of cannabis companies, indicating both advancements and setbacks in the sector. Despite an overall increa
BenzingaApr 11 13:17 ET
Medicine Man Technologies GAAP EPS of -$0.43, Revenue of $43.3M Misses by $2.17M
Seeking AlphaMar 28 11:47 ET
Schwazze Reports Slight Revenue Drop In Q4 2023 Amid 'Fierce' Competition In Cannabis Retail Sector
Medicine Man Technologies, Inc. (OTC:SHWZ), operating as Schwazze, announced its financial and operational results on Thursday for the fourth quarter and full year ended Dec. 31, 2023."This past year,
BenzingaMar 28 11:42 ET
Medicine Man Technologies Is Maintained at Buy by Benchmark
Medicine Man Technologies Is Maintained at Buy by Benchmark
Dow JonesMar 28 11:25 ET
Express News | Benchmark Maintains Buy on Medicine Man Technologies, Lowers Price Target to $2.5
Moomoo 24/7Mar 28 11:15 ET
Medicine Man Technologies Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/28/2024 190.7% Benchmark $3 → $2.5 Maintains Buy 03/30/2023 248.84% Benchmark → $3 Reiterates → Buy 12/
BenzingaMar 28 11:13 ET
Earnings Call Summary | MEDICINE MAN TECHNOLOGIES INC(SHWZ.US) Q4 2023 Earnings Conference
The following is a summary of the Medicine Man Technologies, Inc. (SHWZ) Q4 2023 Earnings Call Transcript:Financial Performance:Medicine Man Technologies (Schwazze) reported Q4 revenue of $43.3 millio
moomoo AIMar 27 22:01 ET · Conference Call
Medicine Man Technologies Q4 EPS $(0.38) Misses $(0.13) Estimate, Sales $43.33M Miss $45.47M Estimate
Medicine Man Technologies (OTC:SHWZ) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.13) by 192.31 percent. This is a 22.58 percent decrease over loss
BenzingaMar 27 16:50 ET
Earnings Flash (SHWZ) SCHWAZZE Reports Q4 Revenue $43.3M
04:14 PM EDT, 03/27/2024 (MT Newswires) -- Earnings Flash (SHWZ) SCHWAZZE Reports Q4 Revenue $43.3M
MT NewswiresMar 27 16:14 ET
Press Release: Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results
Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results Canada NewsWire DENVER, March 27, 2024 FY 2023 Revenue of $172.4 Million; Income from Operations of $3.3 Million; Adjusted EBI
Dow JonesMar 27 16:05 ET
Medicine Man Technologies 4Q Rev $43.3M >SHWZ
Medicine Man Technologies 4Q Rev $43.3M >SHWZ
Dow JonesMar 27 16:05 ET
Medicine Man Technologies Q4 2023 Earnings Preview
Seeking AlphaMar 26 17:35 ET
Notable Earnings After Wednesday's Close
Seeking AlphaMar 26 17:35 ET
Earnings Outlook For Medicine Man Technologies
Medicine Man Technologies (OTC:SHWZ) is set to give its latest quarterly earnings report on Wednesday, 2024-03-27. Here's what investors need to know before the announcement.Analysts estimate that Med
BenzingaMar 26 11:01 ET
Schwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 P.m. ET
Yahoo FinanceMar 12 16:30 ET
Press Release: Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer
Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer PR Newswire DENVER, Feb. 23, 2024 DENVER, Feb. 23, 2024 /PRNewswire/ - Medicine Man Technologies, Inc., operating as Schwazze
Dow JonesFeb 23 07:32 ET
Fast Track Recap: Colorado & Michigan Weed Sales Decline, Virginia Eyes Legal Market, Stock Winners & Losers
Colorado's cannabis market, once a frontrunner in the U.S. for recreational marijuana sales, has experienced a downturn. In 2023, the state's cannabis sales barely surpassed the $1.5 billion mark, a d
BenzingaFeb 12 18:57 ET
No Data
No Data